Ledger.Open graph →
SEC Form D · Amendment · filed March 23, 2026

ADAPTIN BIO, INC

Offering
$4.0M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHARLOTTE, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

David J. Patterson · Portland, ORExecJohn O'Connor · San Francisco, CADirectorJames Palmisciano · New York, NYDirectorHue Rhodes · New York, NYExecMichael Pettinella · New York, NYExec · DirectorJoshua Elwell · New York, NYExec · DirectorArdalan Khosrowpour · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗